X

熱門

Letters from leaders of Hong Kong's political parties and government departments.

    Letter To Hong Kong

    簡介

    GIST

                                                                   
    Politicians and public figures from a range of backgrounds take turns to have their say on important matters of the day in this personal view programme.

    Catch it live: Sunday 8:15am - 8:25am

    Podcast: Updated weekly and available after broadcast. 


    最新

    LATEST
    30/05/2021
    相片集
    相片集

    Allan Zeman, chairman of the Lan Kwai Fong Group

    Almost a year and a half has passed since the pandemic started, we are still surviving.

    This is definitely not easy. There is virtually no night life in Hong Kong as known a city never sleeps. The last two years have been hard for all the industries especially the F&B. But I know there is nothing more important than being safe and healthy.

     

    I have been through a lot of ups and downs in my 50 years in Hong Kong. The past two years have been the most difficult. Social protests and months of restricted openings left many bars and restaurants struggling to survive, and that’s really something I have not experienced in Lan Kwai Fong. I estimated more than one-third of bars in Hong Kong had been closed. Luckily we are now allowed to operate until 2am under the vaccine bubble. It is a good start, I hope things will continue to go our way. COVID19 changes our lives in so many ways. There have been tremendous changes in the dining industry. Now that people are going out much less often and drink more at home. As a result, delivery business has been booming. Crisis brings changes. We should try to leverage this opportunity because the home dining concept might continue even in the post pandemic period.

     

    Personally I felt much healthier during the pandemic and enjoyed some quality times with my family especially with my grandchildren. Crisis also brings opportunity, especially in Hong Kong, a magical place to make your dream come true. I have never lost confidence in the city I love. We should learn to live with the pandemic and try every way to return our lives to normal. We must be prepared for what will come next.

     

    Hong Kong was stuck for a while. This started with the social movement two years ago when many people took to the streets to air their political grievances and tried to destroy the city. The extreme violence, which I could often recall from these horrible scenes from TV footage, served no good to anyone and complicated the already geo-political situation between the east and the west. Ironically, the pandemic brought an end to all protests. With the passing of the national security law, we finally started to have our peace back. I am also happy to see the change in the electoral system. Hong Kong government will now be able to speed up solving those deep-seated, acute problems, such as the housing issue and land shortage.

     

     

    We must respect, not criticize because we are Chinese after all. That is something we cannot deny. Patriotism will help unblock the roadblocks that we've faced all these years. Let’s not forget the DNA of Hong Kong, the name Hong Kong is a strong brand in the world and will be stronger if it continues to integrate into the overall development of the nation. Our strength in financial services, backed by its common law system and independent judiciary, makes Hong Kong a global business center, and that has not changed.

     

     

    The integration of Hong Kong into the Greater Bay Area will be our future. With 72 million people and ranked as the world’s Top 10 in terms of GDP, it is Hong Kong’s solution to stay competitive to be an innovative and financial powerhouse that could surpass rival Silicon Valley and Tokyo Bay Area in a few years. I urge all the young people to look at things with different eyes and see things other people do not see. I always look at things as "not what they are, but what they could be". The GBA shows tremendous promise. Last year, the gross domestic product in the area reached US$1.65 trillion. By 2030, it is likely to have 80 million people and the GDP could grow to US$3.5 trillion. Hong Kong, Macao, Shenzhen and Guangzhou are four economic pillars in the area. Every city has its own uniqueness and they can work together as a family but still be competitive. These could present many opportunities for young people in the area in many years to come.

     

    Like almost everyone else in Hong Kong, I look forward to the day of the border open, the travel on high-speed rail and also travel on the Hong Kong-Zhuhai-Macao Bridge. I used to travel every week. But I have not done so for 18 months. I missed travelling. Of course, to make it happen, we must try our best to maintain zero infections in this city. We all should go get vaccinated because it is the best way to protect ourselves and our family and friends. With a higher vaccination rate, it is likely we can catch up with other international cities to welcome more tourists and get back to normal.

     

    Let’s keep our efforts up, be positive, and welcome the new one country two systems with Chinese characteristics. We are always the best. I look forward to seeing you all in Lan Kwai Fong. Hong Kong has such great future for everyone.

     

    (end)

     

    30/05/2021 - 足本 Full (HKT 08:15 - 08:25)

    重溫

    CATCHUP
    03 - 05
    2021
    香港電台第三台

    30/05/2021

    Allan Zeman, chairman of the Lan Kwai Fong Group

    23/05/2021

    Mrs. Ayesha Macpherson Lau, Chairman of the Mandatory Provident Fund Schemes Authority

    16/05/2021

    Ricky CHU Man-kin, Chairperson of the Equal Opportunities Commission

    09/05/2021

     Dr Gabriel Choi, president of the Hong Kong Medical Association

    02/05/2021

    Executive Councillor Ronny Tong

    25/04/2021

    Professor Ho Lok-sang, Senior Research Fellow, Pan Sutong Shanghai-HK Economic Policy Research Institute, Lingnan University

    18/04/2021

    Albert Wong, Chief Executive Officer, Hong Kong Science and Technology Parks Corporation

    11/04/2021

    Chief Secretary Matthew Cheung Kin-chung

    04/04/2021

     Dr Eugene Chan, President of the Society of Hong Kong Professionals

    28/03/2021

    Lo Kin-hei, chairman of the Democratic Party, and chairman of Southern District Council
    X

    Professor Ivan Hung

    Dear Uncle Kay

     

    Over the past one year, the Covid19 pandemic has affected 191 countries, with more than 75 million people infected and in excess of 1.6 million deaths. The situation was particularly bad in the United States, the country where you live. With more than 200,000 patients diagnosed every day, we can't help but worry about you! In these ten long months, Hong Kong has experienced wave after wave of outbreaks. All social and business activities were put on halt. The economy has suffered hefty losses. We are playing catch up with this very smart virus. Its mutation rate is astonishing as highlighted by the D614G mutation of the surface spike protein which greatly enhanced its transmissibility. In Hong Kong, we are currently experiencing the “fourth wave” of the outbreak, initially started by a dance cohort and have resulted in almost 2000 new cases since late November. Despite being highly contagious, the virus virulence remains unchanged as the current circulating clade was the same Nepalese clade identified late September. Most severe cases required intensive care are elderly patients with comorbidity, although a few young patients with high viral carriage who presented late to the hospitals might also presented with deterioration. The cold weather might also increase the viral replication in the nasal passage and upper respiratory tract.

     

     

     

    In your previous letter, you asked whether you should receive the Covid19 vaccine once available. I fully understand your doubt as this is a completely new vaccine, without long-term safety and efficacy data. With regards to the Covid19 vaccine technology, there are three main platforms. The first type is the conventional vector based vaccine, which relies on the adenovirus to deliver the spike protein genetic code into human cells, which then produce the protein and prepare the immune system to respond to a future infection. The second type is a completely new platform, using gene editing and modification technology to make messenger RNA of the coronavirus surface spike protein into the vaccine. Once injected into the human body, the immune system will recognize the translated spike protein and start producing antibody against the coronavirus. The third type is a Covid19 recombinant spike protein nanoparticle vaccine with adjuvant, which is also a relatively new technology. In the usual circumstance, it will take 5 to 10 years for a new vaccine to develop from the laboratory to go into the market. First, the vaccine must go through animal testing, followed by a three-stage human clinical trials. The final report must be approved by the local authorities (for example the Food and Drug Safety Administration in the US) before vaccination in the human subjects. However, since the health system of many countries are close to collapse, Covid19 vaccine pharmaceuticals have been given special rights to expedite the clinical trials process, in which the US and UK have already launched the community vaccination program based on the recently published phase III vaccine trial short-term results, with reported efficacy of 95% and 70% respectively. The pharmaceuticals are also given special exemption from liability clauses with regards to adverse effects due to the vaccine. Nevertheless, the vaccine manufacturers still have to take responsibility to ensure the quality of the vaccines. Despite recent worrying reports of facial palsy after the Covid19 vaccination in a few of the trial patients, there are no evidence to suggest these adverse events were associated with the vaccine as similar incidents were also reported in the placebo group. With regards to the long-term results, we have yet to know the one-year or beyond vaccine efficacy and safety. As we previously reported of the world first case of reinfection, we understand that the antibody will drop to an undetectable level over a period of around 6 months. It is likely that similar to the influenza vaccine, annual COVID19 vaccination will be required and vigilance in infection control and face masking might still be needed.

     

     

     

    In view of your age and past medical history of diabetes and obesity, I would strongly recommend you to receive the vaccine once available. We learn from our past experience that elderly patients, especially those with chronic illnesses of diabetes, cardiac and pulmonary diseases, immunosuppressed hosts and cancer patients on chemotherapy are at high risks of deterioration and complication of developing of severe pneumonia upon contracting COVID19. These high risk patients should be hospitalized once they are diagnosed and should be started on a combination of antiviral treatment as soon as possible, in order to suppress the viral replication and reduce the risks of subsequent complications and pneumonia associated with the hyperinflammation phase in the second week of the infection.

     

     

     

    In your previous letter, you also expressed concern about whether the poorer countries will get a fair share of the vaccines. For this, you could rest assured.  The International organization COVAX will be responsible for distributing the Covid-19 vaccines fairly among different countries. The COVAX, co-led by the Global Alliance for Vaccine Immunity (GAVI), the Coalition for Epidemic Preparedness Innovations (CEPi), and the World Health Organization (WHO). Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world. The coalition hopes to provide 2.1 billion doses of safe and effective vaccines in 2021, and to distribute them to all COVAX participating countries fairly according to the population, so as to provide a certain degree of safety net for poor countries.

     

     

     

    At the University of Hong Kong, we have developed an intranasal COVID19 vaccine based on an influenza vaccine platform. Hopefully, we will be able to kick start the phase 1 clinical trial on this vaccine early next year. If successful, we will be able to proceed to Phase 3 clinical trial later next year globally. This vaccine has the potential of conferring local immunity at the nasal passage and could combine the seasonal flu and Covid19 as a single vaccine to be given annually. 

     

     

     

    Hopefully, the universal COVID19 vaccination coupled with the natural infection will shorten the time to achieve herd immunity globally, so that social, economic and traveling activities could be resumed. I look forward to visiting you in San Francisco next year. Merry Christmas and Happy New Year.

     

     

     

    Warmest regards

     

    Ivan

    香港電台第三台

    20/12/2020 - 足本 Full (HKT 08:15 - 08:25)

    • 網站獲奬:

    • 在新分頁開啟第五屆傳媒轉型大獎
    • 在新分頁開啟2014優秀網站選舉十大優秀網站